3.99

1.79% 0.07

After Hours: 4.09 0.10 +2.51%

Cytek Biosciences Inc (CTKB)

Overview News Price History Option Chain Financials Discussions Forecast

Cytek Biosciences Inc stock is traded at $3.99, with a volume of 838.33K. It is up +1.79% in the last 24 hours and down -11.14% over the past month. Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Previous Close:

$3.92

Open:

$3.9

24h Volume:

838.33K

Relative Volume:

1.04

Market Cap:

$502.14M

Revenue:

$193.01M

Net Income/Loss:

$-12.15M

P/E Ratio:

-44.33

EPS:

-0.09

Net Cash Flow:

$454.00K

1W Performance:

-2.21%

1M Performance:

-11.14%

6M Performance:

-23.85%

1Y Performance:

-38.80%

1-Day Range:

$3.88

$4.10

1-Week Range:

$3.88

$4.16

52-Week Range:

$3.88

$7.63

Cytek Biosciences Inc Stock (CTKB) Company Profile

Name

Cytek Biosciences Inc

Sector

Healthcare (1183)

Industry

Medical Devices (160)

Phone

(877) 922-9835

Address

47215 LAKEVIEW BOULEVARD, FREMONT

Employee

648

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

CTKB's Discussions on Twitter

Compare CTKB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CTKB Cytek Biosciences Inc	3.99	502.14M	193.01M	-12.15M	454.00K	-0.09
ABT Abbott Laboratories	131.93	228.81B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	100.05	149.74B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	377.46	142.48B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	88.86	113.49B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	72.05	42.10B	5.72B	4.17B	259.90M	6.97

Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-31-25	Downgrade	Goldman	Buy → Sell
Dec-14-23	Initiated	Stephens	Overweight
Jul-19-23	Initiated	Raymond James	Mkt Perform
Jan-06-22	Resumed	Piper Sandler	Overweight

Cytek Biosciences Inc Stock (CTKB) Latest News

09:28 AM

Cell Analyzer | Cytek Biosciences Inc. | Products - Photonics Spectra

09:28 AM

Mar 31, 2025

106,597 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Purchased by Teacher Retirement System of Texas - Defense World

Mar 31, 2025

Mar 29, 2025

Proficio Capital Partners LLC Invests $71,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Mar 29, 2025

Mar 28, 2025

Cytek Biosciences stock hits 52-week low at $3.99 amid market shifts - Investing.com

Mar 28, 2025

Mar 27, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by PNC Financial Services Group Inc. - Defense World

Mar 27, 2025

Cytek Biosciences expands cell analysis offerings with the affordable, user-friendly Cytek Muse Micro System - SelectScience

Mar 27, 2025

Mar 24, 2025

Charles Schwab Investment Management Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Mar 24, 2025

Mar 23, 2025

Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.2% – What’s Next? - Defense World

Mar 23, 2025

Mar 21, 2025

Stephens Reiterates “Overweight” Rating for Cytek Biosciences (NASDAQ:CTKB) - Defense World

Mar 21, 2025

Mar 20, 2025

Cytek Biosciences stock hits 52-week low at $4.05 - Investing.com India

Mar 20, 2025

Cytek Biosciences stock hits 52-week low at $4.05 By Investing.com - Investing.com UK

Mar 20, 2025

Mar 18, 2025

Cytek Biosciences Launches Next-Generation Muse Micro Cell Analyzer to Transform Flow Cytometry Accessibility - Nasdaq

Mar 18, 2025

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System - GlobeNewswire

Mar 18, 2025

Revolutionary Budget-Friendly Cell Analyzer Transforms Biotech Research Accessibility - StockTitan

Mar 18, 2025

Bank of New York Mellon Corp Grows Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Mar 18, 2025

Mar 14, 2025

Proficio Capital Partners LLC Takes Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Mar 14, 2025

Mar 12, 2025

Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges - Investing.com Australia

Mar 12, 2025

Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 10, 2025

Cytek Biosciences (CTKB) to Release Earnings on Wednesday - The AM Reporter

Mar 10, 2025

Mar 08, 2025